找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 SCIE期刊BIODRUGS 2024/2025影响因子:5.406 (BIODRUGS) (1173-8804). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index Expa  ...234
Total Citations:2891; 2023 JIF:5.406; JIFRank: 32/354 ; Rank-JIF: 32; Number-of-JIF:354; 5 Year JIF:5.306; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.1; Immediacy Index:1.3; Immediacy Index-dealt:1.392; 2023 JCI:1.07; JCI Rank: 73/354 ; Total Articles:29; JCI Quartile:Q1; JCI Percentile:77.8; Eigenfactor:0.003; Normalized Eigenfactor:0.733; Article Influence Score:1.455; JIF Percentile:81.5; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:62; % of Articles in Citable items:0.4677; Cited Half-Life:5.6; Citing Half-Life:5.9; % of OA Gold:0.5; Publisher name:EDITORA UNISINOS; Publisher address:DIVISAO DE PERIODICIOS, CAIXA POSTAL 275, SAO
投票 SCIE期刊Pharmaceuticals 2024/2025影响因子:4.347 (PHARMACEUTICALS-BASE) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citat  ...234
Total Citations:21199; 2023 JIF:4.347; JIFRank: 69/354 ; Rank-JIF: 69; Number-of-JIF:354; 5 Year JIF:4.638; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.1; Immediacy Index:1.1; Immediacy Index-dealt:1.172; 2023 JCI:1.08; JCI Rank: 71/354 ; Total Articles:1218; JCI Quartile:Q1; JCI Percentile:80.08; Eigenfactor:0.024; Normalized Eigenfactor:5.349; Article Influence Score:0.798; JIF Percentile:80.6; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:1704; % of Articles in Citable items:0.7148; Cited Half-Life:2.4; Citing Half-Life:6.9; % of OA Gold:0.997; Publisher name:BRISTOL UNIV PRESS & POLICY PRESS; Publisher address:1-9 OLD PARK HILL, UN
投票 SCIE期刊Therapeutic Advances in Psychopharmacology 2024/2025影响因子:3.487 (THER ADV PSYCHOPHARM) (2045-1253). (PHARMACOLOGY  ...234
Total Citations:1416; 2023 JIF:3.487; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:4.387; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.3; Immediacy Index:0.9; Immediacy Index-dealt:0.982; 2023 JCI:0.76; JCI Rank: 136/354 ; Total Articles:14; JCI Quartile:Q2; JCI Percentile:58.51; Eigenfactor:0.002; Normalized Eigenfactor:0.461; Article Influence Score:1.285; JIF Percentile:71.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:33; % of Articles in Citable items:0.4242; Cited Half-Life:5.1; Citing Half-Life:6.8; % of OA Gold:0.918; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDO
投票 SCIE期刊CLINICAL PHARMACOLOGY & THERAPEUTICS 2024/2025影响因子:6.35 (CLIN PHARMACOL THER) (0009-9236). (PHARMACOLOGY & PHARMA  ...234
Total Citations:18906; 2023 JIF:6.35; JIFRank: 25/354 ; Rank-JIF: 25; Number-of-JIF:354; 5 Year JIF:6.225; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.8; Immediacy Index:1.1; Immediacy Index-dealt:1.185; 2023 JCI:1.64; JCI Rank: 22/354 ; Total Articles:194; JCI Quartile:Q1; JCI Percentile:93.93; Eigenfactor:0.021; Normalized Eigenfactor:1.431; Article Influence Score:1.415; JIF Percentile:93.1; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:231; % of Articles in Citable items:0.8398; Cited Half-Life:8.4; Citing Half-Life:5.9; % of OA Gold:0.4317; Publisher name:ELSEVIER SCIENCE INC; Publisher address:STE 800, 230 PARK AVE, NEW YORK, USA
投票 SCIE期刊TOXICOLOGY 2024/2025影响因子:4.817 (TOXICOLOGY) (0300-483X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index  ...234
Total Citations:14190; 2023 JIF:4.817; JIFRank: 50/354 ; Rank-JIF: 50; Number-of-JIF:354; 5 Year JIF:4.413; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.7; Immediacy Index:0.9; Immediacy Index-dealt:0.924; 2023 JCI:1.27; JCI Rank: 46/354 ; Total Articles:178; JCI Quartile:Q1; JCI Percentile:90.09; Eigenfactor:0.007; Normalized Eigenfactor:1.449; Article Influence Score:0.855; JIF Percentile:87.3; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:182; % of Articles in Citable items:0.978; Cited Half-Life:11.4; Citing Half-Life:6.9; % of OA Gold:0.1852; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE
投票 SCIE期刊JOURNAL OF ETHNOPHARMACOLOGY 2024/2025影响因子:4.805 (J ETHNOPHARMACOL) (0378-8741). (PHARMACOLOGY & PHARMACY)(药理学与药学  ...234
Total Citations:52832; 2023 JIF:4.805; JIFRank: 50/354 ; Rank-JIF: 50; Number-of-JIF:354; 5 Year JIF:4.843; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.3; Immediacy Index:0.9; Immediacy Index-dealt:0.998; 2023 JCI:1.42; JCI Rank: 30/354 ; Total Articles:1196; JCI Quartile:Q1; JCI Percentile:87.21; Eigenfactor:0.024; Normalized Eigenfactor:5.205; Article Influence Score:0.656; JIF Percentile:91.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:1281; % of Articles in Citable items:0.9336; Cited Half-Life:7.9; Citing Half-Life:5.9; % of OA Gold:0.1139; Publisher name:JACK H BERRYMAN INST; Publisher address:UTAH STATE UNIV, DEPT WILDLAND RE
投票 SCIE期刊AAPS PHARMSCITECH 2024/2025影响因子:3.476 (AAPS PHARMSCITECH) (1530-9932). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science C  ...234
Total Citations:11853; 2023 JIF:3.476; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:3.556; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:1; Immediacy Index-dealt:1.147; 2023 JCI:0.93; JCI Rank: 95/354 ; Total Articles:180; JCI Quartile:Q2; JCI Percentile:73.31; Eigenfactor:0.006; Normalized Eigenfactor:NULL; Article Influence Score:NULL; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:220; % of Articles in Citable items:0.8182; Cited Half-Life:6.4; Citing Half-Life:6.6; % of OA Gold:0.1486; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United
投票 SCIE期刊CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS 2024/2025影响因子:3.139 (CRIT REV THER DRUG) (0743-4863). (PHARM  ...234
Total Citations:1254; 2023 JIF:3.139; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.524; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.6; Immediacy Index:0.5; Immediacy Index-dealt:0.594; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:0; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0; Normalized Eigenfactor:0.065; Article Influence Score:0.452; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:17; % of Articles in Citable items:0; Cited Half-Life:11.1; Citing Half-Life:9.3; % of OA Gold:0.0192; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDON, Engl
投票 SCIE期刊JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 2024/2025影响因子:2.923 (J CLIN PSYCHOPHARM) (0271-0749). (PHARMACOLOGY & PHAR  ...234
Total Citations:4693; 2023 JIF:2.923; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:3.178; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.7; Immediacy Index:1; Immediacy Index-dealt:1.135; 2023 JCI:0.65; JCI Rank: 177/354 ; Total Articles:53; JCI Quartile:Q3; JCI Percentile:45.47; Eigenfactor:0.003; Normalized Eigenfactor:0.562; Article Influence Score:0.844; JIF Percentile:64.7; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:61; % of Articles in Citable items:0.8689; Cited Half-Life:11.7; Citing Half-Life:9.1; % of OA Gold:0.1659; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDO
投票 SCIE期刊EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS 2024/2025影响因子:4.435 (EUR J PHARM BIOPHARM) (0939-6411). (P  ...234
Total Citations:18796; 2023 JIF:4.435; JIFRank: 65/354 ; Rank-JIF: 65; Number-of-JIF:354; 5 Year JIF:4.829; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.3; Immediacy Index:1; Immediacy Index-dealt:1.151; 2023 JCI:1.41; JCI Rank: 32/354 ; Total Articles:221; JCI Quartile:Q1; JCI Percentile:91.1; Eigenfactor:0.008; Normalized Eigenfactor:1.693; Article Influence Score:0.713; JIF Percentile:81.8; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:237; % of Articles in Citable items:0.9325; Cited Half-Life:8.3; Citing Half-Life:7.8; % of OA Gold:0.2861; Publisher name:ARAS PART MEDICAL INT PRESS; Publisher address:NO 1, S SHAREATI ST, 5138815941
投票 SCIE期刊DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY 2024/2025影响因子:2.401 (DRUG DEV IND PHARM) (0363-9045). (PHARMACOLOGY & PH  ...234
Total Citations:7802; 2023 JIF:2.401; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:3.334; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.3; Immediacy Index:0.7; Immediacy Index-dealt:0.727; 2023 JCI:0.79; JCI Rank: 130/354 ; Total Articles:81; JCI Quartile:Q2; JCI Percentile:63.42; Eigenfactor:0.003; Normalized Eigenfactor:0.621; Article Influence Score:0.442; JIF Percentile:47; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:83; % of Articles in Citable items:0.9759; Cited Half-Life:8.3; Citing Half-Life:6.9; % of OA Gold:0.0322; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAMBR
投票 SCIE期刊Indian Journal of Pharmaceutical Education and Research 2024/2025影响因子:0.827 (INDIAN J PHARM EDUC) (0019-5464). (P  ...234
Total Citations:1227; 2023 JIF:0.827; JIFRank: 311/354 ; Rank-JIF: 311; Number-of-JIF:354; 5 Year JIF:0.866; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.7; Immediacy Index:0.1; Immediacy Index-dealt:0.149; 2023 JCI:0.29; JCI Rank: 293/354 ; Total Articles:219; JCI Quartile:Q4; JCI Percentile:17.37; Eigenfactor:0.001; Normalized Eigenfactor:0.175; Article Influence Score:0.103; JIF Percentile:12.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:243; % of Articles in Citable items:0.9012; Cited Half-Life:4.5; Citing Half-Life:9.1; % of OA Gold:0.9778; Publisher name:IOP PUBLISHING LTD; Publisher address:TEMPLE CIRCUS, TEMPLE WAY, BRISTOL,
投票 SCIE期刊International Journal of Nanomedicine 2024/2025影响因子:6.691 (INT J NANOMED) (1178-2013). (PHARMACOLOGY & PHARMACY)(  ...234
Total Citations:39713; 2023 JIF:6.691; JIFRank: 20/354 ; Rank-JIF: 20; Number-of-JIF:354; 5 Year JIF:7.576; 5 Year JIF Quartile:Q1; JIF Without Self Cites:6.4; Immediacy Index:1.1; Immediacy Index-dealt:1.192; 2023 JCI:1.29; JCI Rank: 43/354 ; Total Articles:336; JCI Quartile:Q1; JCI Percentile:87.99; Eigenfactor:0.025; Normalized Eigenfactor:5.365; Article Influence Score:1.065; JIF Percentile:94.5; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:434; % of Articles in Citable items:0.7742; Cited Half-Life:5.6; Citing Half-Life:5.1; % of OA Gold:0.9845; Publisher name:FEDERAL RESERVE BANK ST LOUIS; Publisher address:BOX 442, ST LOUIS, USA, MO
投票 SCIE期刊PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 2024/2025影响因子:3.318 (PHARMACOL BIOCHEM BE) (0091-3057). (PHARMACOLOGY & PH  ...234
Total Citations:10449; 2023 JIF:3.318; JIFRank: 118/354 ; Rank-JIF: 118; Number-of-JIF:354; 5 Year JIF:3.231; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.1; Immediacy Index:0.5; Immediacy Index-dealt:0.523; 2023 JCI:0.88; JCI Rank: 105/354 ; Total Articles:88; JCI Quartile:Q2; JCI Percentile:61.13; Eigenfactor:0.005; Normalized Eigenfactor:1.066; Article Influence Score:0.937; JIF Percentile:60.2; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:95; % of Articles in Citable items:0.9263; Cited Half-Life:14.3; Citing Half-Life:10; % of OA Gold:0.2719; Publisher name:SPRINGER JAPAN KK; Publisher address:SHIROYAMA TRUST TOWER 5F, 4-3-1 TORAN
投票 SCIE期刊EUROPEAN NEUROPSYCHOPHARMACOLOGY 2024/2025影响因子:6.196 (EUR NEUROPSYCHOPHARM) (0924-977X). (PHARMACOLOGY & PHARMACY  ...234
Total Citations:8533; 2023 JIF:6.196; JIFRank: 26/354 ; Rank-JIF: 26; Number-of-JIF:354; 5 Year JIF:5.326; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.6; Immediacy Index:2; Immediacy Index-dealt:2.196; 2023 JCI:1.27; JCI Rank: 46/354 ; Total Articles:61; JCI Quartile:Q1; JCI Percentile:80.48; Eigenfactor:0.009; Normalized Eigenfactor:1.916; Article Influence Score:1.74; JIF Percentile:89.5; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:83; % of Articles in Citable items:0.7349; Cited Half-Life:7.6; Citing Half-Life:7.3; % of OA Gold:0.3712; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDON, E
投票 SCIE期刊PLANTA MEDICA 2024/2025影响因子:2.111 (PLANTA MED) (0032-0943). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Ind  ...234
Total Citations:13284; 2023 JIF:2.111; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:2.856; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2; Immediacy Index:0.5; Immediacy Index-dealt:0.549; 2023 JCI:0.59; JCI Rank: 203/354 ; Total Articles:74; JCI Quartile:Q3; JCI Percentile:47.67; Eigenfactor:0.002; Normalized Eigenfactor:0.53; Article Influence Score:0.435; JIF Percentile:54.7; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:85; % of Articles in Citable items:0.8706; Cited Half-Life:15.1; Citing Half-Life:7.8; % of OA Gold:0.0707; Publisher name:ASCE-AMER SOC CIVIL ENGINEERS; Publisher address:1801 ALEXANDER BELL DR, RES
投票 SCIE期刊ADVANCES IN THERAPY 2024/2025影响因子:3.408 (ADV THER) (0741-238X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation  ...234
Total Citations:8849; 2023 JIF:3.408; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:4.137; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:0.7; Immediacy Index-dealt:0.719; 2023 JCI:0.79; JCI Rank: 130/354 ; Total Articles:266; JCI Quartile:Q2; JCI Percentile:63.42; Eigenfactor:0.014; Normalized Eigenfactor:3.131; Article Influence Score:1.152; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:345; % of Articles in Citable items:0.771; Cited Half-Life:3.9; Citing Half-Life:5.4; % of OA Gold:0.6888; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Uni
投票 SCIE期刊CLINICAL AND EXPERIMENTAL HYPERTENSION 2024/2025影响因子:1.598 (CLIN EXP HYPERTENS) (1064-1963). (PHARMACOLOGY & PHAR  ...234
Total Citations:2156; 2023 JIF:1.598; JIFRank: 265/354 ; Rank-JIF: 265; Number-of-JIF:354; 5 Year JIF:1.608; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.4; Immediacy Index:0.9; Immediacy Index-dealt:0.931; 2023 JCI:0.49; JCI Rank: 243/354 ; Total Articles:77; JCI Quartile:Q3; JCI Percentile:31.5; Eigenfactor:0.002; Normalized Eigenfactor:0.339; Article Influence Score:0.357; JIF Percentile:25.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:77; % of Articles in Citable items:1; Cited Half-Life:6.9; Citing Half-Life:5.7; % of OA Gold:0.3712; Publisher name:CAB-CENTER LIBRARIES FEDERICO II UNIV NAPLES; Publisher address:PIAZZA BELLINI 59
投票 SCIE期刊INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES 2024/2025影响因子:0.437 (INDIAN J PHARM SCI) (0250-474X). (PHARMACOLOGY & P  ...234
Total Citations:3350; 2023 JIF:0.437; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.694; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:<0.1; Immediacy Index-dealt:0.009; 2023 JCI:0.11; JCI Rank: 337/354 ; Total Articles:388; JCI Quartile:Q4; JCI Percentile:4.94; Eigenfactor:0.001; Normalized Eigenfactor:0.219; Article Influence Score:0.089; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:414; % of Articles in Citable items:0.9372; Cited Half-Life:11.3; Citing Half-Life:6.5; % of OA Gold:0.2351; Publisher name:SPRINGER INT PUBL AG; Publisher address:GEWERBESTRASSE 11, CHAM, SWITZERL
投票 SCIE期刊NEUROTOXICOLOGY 2024/2025影响因子:3.425 (NEUROTOXICOLOGY) (0161-813X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citat  ...234
Total Citations:7562; 2023 JIF:3.425; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:3.601; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:0.7; Immediacy Index-dealt:0.724; 2023 JCI:0.98; JCI Rank: 84/354 ; Total Articles:101; JCI Quartile:Q1; JCI Percentile:76.41; Eigenfactor:0.005; Normalized Eigenfactor:1; Article Influence Score:0.738; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:107; % of Articles in Citable items:0.9439; Cited Half-Life:8; Citing Half-Life:8.3; % of OA Gold:0.2743; Publisher name:SPRINGER PUBLISHING CO; Publisher address:11 WEST 42ND STREET, NEW YORK, USA, NY
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 20:44
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块